EN DE
Watch Cho Bi for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Cho Bi (001550) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Cho Bi stock KRW 8,154, price KRW 9,120, that is 10.6% below the price, quality 51 out of 100. Rating: overvalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials KR · ISIN KR7001550003

CB Cho Bi logo Some data Nov 3, 2026

Cho Bi

001550 · KO
Expensive, in a downtrend

Our calculation puts a fair price 11% below what the stock costs today.

Low debt
Generates free cash flow
Quality 51/100
Thin margins · 0.1% net margin (TTM)
Some data
Revenue last quarter 10% below a year ago.
Fair value 8,154 KRW · Overvalued
Weak Growth (revenue 3y −12.4 %/yr in KRW)
Trails peers (4/12)
Narrow moat 19/100
⟳ Cyclical
Watch Cho Bi for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

33,250 KRW 9,080 KRW Fair Value 8,154 KRW Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

60‑month range 9,080 KRW – 33,250 KRW · fair‑value band 7,074 KRW – 9,102 KRW · the 9,120 KRW price screens above the 8,154 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow Cho Bi in your weekly email

Every Wednesday you see whether Cho Bi is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Chobi Company Limited produces and distributes composite fertilizers in South Korea. It offers hydrophonic fertilizers, controlled release fertilizers, MCF organic fertilizers, and PNS CRF fertilizers.

Show moreShow less

The company was formerly known as Chosun Fertilizer Industry Co., Ltd. and changed its name to Chobi Company Limited in October 1990. Chobi Company Limited was founded in 1955 and is headquartered in Seoul, South Korea. Chobi Company Limited is a subsidiary of Kyung Nong Corporation.

Stock analysis

Cho Bi (001550) currently trades at 9,120 KRW, while our model-based Fair Value estimate is 8,154 KRW, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of 10,434 KRW per share, and 8 of the 22 models we run sit above the 9,120 KRW price.

Bear case: the Multiples group reads lowest at 4,875 KRW, and 14 of the 22 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 7,074 KRW (bear) to 9,102 KRW (bull), the price of 9,120 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Cho Bi reported revenue of 99.7B KRW in FY2025 versus 84.6B KRW in FY2021, a compound +4.2%/yr. Reported net income was 2.0B KRW in FY2025, compounding +1.6%/yr from FY2021.

Key figures

Market cap 47.3B KRW (≈ $35.0M) Micro · P/S ratio 0.84 · EPS (TTM) 9.63 KRW · Net margin 0.1% · Return on equity 0.1% · Return on assets (EBIT) 2.9% (5-year average) · Operating margin −19.1% · Revenue (TTM) 58.5B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (medium confidence).

What moves the price

The share trades about 48% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at 5% fair-value upside, at −11%, 001550 screens richer than that median.

Fair Value models

Bear 7,074 KRW Fair Value 8,154 KRW Bull 9,102 KRW
Price 9,120 KRW · Downside -10.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (8.25 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 7,285 KRW 10,351 KRW 14,813 KRW 78
Growth DCF 7,476 KRW 10,315 KRW 14,261 KRW 77
EPV 7,074 KRW 8,154 KRW 9,102 KRW 74
All 22 models by family
DCF Models
FCF DCF 7,285 KRW 10,351 KRW 14,813 KRW 78
5Y Revenue Exit 7,091 KRW 10,495 KRW 14,700 KRW 70
5Y EBITDA Exit 7,605 KRW 11,415 KRW 15,681 KRW 73
5Y P/E Exit 5,779 KRW 8,146 KRW 10,497 KRW 69
10Y Revenue Exit 6,906 KRW 9,981 KRW 13,818 KRW 65
10Y EBITDA Exit 7,426 KRW 10,609 KRW 14,541 KRW 67
10Y P/E Exit 6,275 KRW 8,380 KRW 10,720 KRW 63
Earnings-Based
Graham-Dodd 2,584 KRW 6,294 KRW 8,140 KRW 63
PEG = 1.0 1,123 KRW 1,604 KRW 2,085 KRW 55
EPV 7,074 KRW 8,154 KRW 9,102 KRW 74
Multiples
P/E Multiple 4,845 KRW 6,460 KRW 8,075 KRW 63
P/S Multiple 4,845 KRW 6,460 KRW 8,075 KRW 58
P/B Multiple 11,259 KRW 15,012 KRW 18,765 KRW 55
EV/EBIT 233.29 KRW 2,809 KRW 5,384 KRW 57
EV/EBITDA 594.08 KRW 3,290 KRW 5,985 KRW 60
EV/Revenue n/a 2,073 KRW 4,943 KRW 50
Asset-Based
NCAV (Graham) 254.23 KRW 385.19 KRW 481.49 KRW 54
Growth DCF
Growth DCF 7,476 KRW 10,315 KRW 14,261 KRW 77
Rev-Margin DCF 7,091 KRW 10,553 KRW 14,296 KRW 71
Economic Profit
Residual Income 7,823 KRW 7,684 KRW 7,900 KRW 68
ROIC Compounder 7,074 KRW 8,154 KRW 9,102 KRW 70
Growth Earnings
Growth-Adj P/E 3,770 KRW 5,385 KRW 7,001 KRW 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 51/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 32
How much profit the company makes from its sales and capital
Quality Growth 45
Are margins and returns getting better?
Cashflow 37
Do the profits arrive as real cash?
Financial strength 34
Debt, balance sheet and risk of trouble
Investment 99
Does it invest with discipline instead of growing at any price?
Low Volatility 54
How calm the share price moves, does not count
Price momentum 18
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Start year 2020 (pandemic). Over 10 years: +5.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.1%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−4.1% vs 6.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 4%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+28.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +26.2% a year for the price.

001550 screens overvalued: fair value 11% below the price. Compare with Nutrien Ltd →

Compare Cho Bi with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 163 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 51 · Below median
Fair Value upside −10.6% · Above median
Profitability
Return on equity (12 months) 0.1% · Bottom 25%
Return on assets 1.6% · Below median
Net margin (12 months) 0.1% · Bottom 25%
Operating margin (12 months) −19.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −9.7% · Bottom 25%
Balance sheet
Debt / equity 0.02× · Below median

Valuation Multiplesvs Agricultural Inputs median · lower = cheaper

P/B 0.87× · Cheaper than median
P/S (12 months) 0.81× · Cheaper than median
Price / free cash flow (fiscal year) 34.3× · Priciest 25%
EV/EBITDA 17.5× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 18
FUTURE (revenue growth)0 · sector 17
PAST (return on equity)0 · sector 29
HEALTH (low debt)99 · sector 98
DIVIDEND (yield)0 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cho Bi: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cho Bi Fair Value". https://www.fairvalue-calculator.com/stock/001550

Frequently asked questions

Is Cho Bi (001550) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 8,154 KRW versus a price of 9,120 KRW, about 11% lower (overvalued).
What is the fair value of 001550?
Our model-based fair value for Cho Bi is 8,154 KRW (as of Nov 3, 2026), built from audited fundamentals. The current price: 9,120 KRW.
What is the quality score of 001550?
Cho Bi has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cho Bi (001550)?
Our model-based price target is the fair value of 8,154 KRW (as of Nov 3, 2026) from 22 valuation models. Cautious scenario 7,074 KRW, optimistic scenario 9,102 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cho Bi stock forecast for 2026?
Our models put fair value at 8,154 KRW, about 11% lower versus a price of 9,120 KRW (overvalued). Cautious scenario 7,074 KRW, optimistic scenario 9,102 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cho Bi (001550)?
Cho Bi reported trailing-twelve-month revenue of about 58.5B KRW (latest available figure, as of Nov 3, 2026).
What growth is priced into Cho Bi (001550)?
For today's price to be fair in a discounted-cash-flow model, Cho Bi would have to grow free cash flow by +28.8 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.3 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of 001550 use?
Our models discount Cho Bi at 8.9 %: a base by market capitalisation (nano), damped by beta 0.27, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cho Bi that is +28.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Cho Bi (001550) delivered so far?
Over the past 5 years revenue at Cho Bi grew +6.3 % a year. The price currently implies free-cash-flow growth of +28.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cho Bi (001550) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Cho Bi (+28.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cho Bi (001550)?
The free-cash-flow yield on the price is 2.91 %: that much free cash flow Cho Bi produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cho Bi (001550)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cho Bi it is 8,154 KRW per share (as of Nov 3, 2026), against a price of 9,120 KRW. It is the blended result of 22 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Cho Bi stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 001550 trades above its calculated fair value: price 9,120 KRW, fair value 8,154 KRW, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 001550?
No. The price is what the market pays today (9,120 KRW); the fair value is what the company's own numbers justify (8,154 KRW). For Cho Bi the two are 966.18 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cho Bi worth?
The market values Cho Bi at about 47.3B KRW (market capitalisation, as of Nov 3, 2026). Per share that is 9,120 KRW; our models calculate a fair value of 8,154 KRW per share.
What do the bullish and bearish scenarios say about 001550?
Our models span a range for Cho Bi: cautious scenario 7,074 KRW, base 8,154 KRW, optimistic 9,102 KRW per share (as of Nov 3, 2026, price 9,120 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cho Bi (001550)?
Balance-sheet figures for Cho Bi (as of Nov 3, 2026): return on equity 0.1%, debt of 0.02 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 001550 from its 52-week high?
Cho Bi trades at 9,120 KRW, about 48% below its 52-week high of 17,450 KRW and at the low of 9,080 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 8,154 KRW is for.
Which stocks are comparable to Cho Bi?
From the same area (Basic Materials) we also value Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, Yara International ASA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cho Bi stock attractive at the current price?
The data as of Nov 3, 2026: price 9,120 KRW, calculated fair value 8,154 KRW (−11%), Quality Score 51/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 001550 calculated?
We run Cho Bi through 22 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 8,154 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Cho Bi itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cho Bi (001550)?
The closing price on Nov 9, 2026 was 9,120 KRW. Our model-based fair value is 8,154 KRW, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cho Bi right now?
The price sits above our optimistic bull case: the favourable scenario is already priced in. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Cho Bi

How large is the market capitalisation of Cho Bi (001550)?
The market capitalisation of Cho Bi is 47.3B KRW (≈ $35.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cho Bi (001550)?
The price-to-sales ratio of Cho Bi is 0.84 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cho Bi (001550)?
Earnings per share at Cho Bi are 9.63 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Cho Bi (001550)?
The net margin of Cho Bi is 0.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cho Bi (001550)?
The return on equity (ROE) of Cho Bi is 0.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cho Bi (001550)?
On an EBIT basis the return on assets of Cho Bi is 2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cho Bi (001550)?
The operating margin of Cho Bi is −19.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cho Bi (001550)?
Revenue at Cho Bi is growing −9.7% versus a year earlier (3y avg −12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Cho Bi (001550) carry?
The net debt of Cho Bi is 38.9B KRW (fiscal year 2025, ≈ 28.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cho Bi in the live analysis

One click puts Cho Bi on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.